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Background
Whether high platelet reactivity (HPR) at the time of
angiography is associated with worse myocardial reperfu-
sion after primary percutaneous coronary intervention
(PPCI) for ST-segment elevation myocardial infarction
(STEMI) is unknown. This study aimed to assess the
impact of HPR on infarct size and reperfusion injury
determined by cardiac magnetic resonance (CMR) in
patients with STEMI undergoing PPCI.
Methods
Patients with STEMI undergoing PPCI and pretreated
with a P2Y12-receptor antagonist (clopidogrel, prasugrel
or ticagrelor) underwent platelet function testing at the
time of angiography and a CMR from 7 to 10 days after
the index event. Platelet function testing was performed
with the VerifyNow assay. HPR was defined according
to expert consensus definitions. Central core laboratory-
masked analyses for quantified ventricular function,
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volumes, infarct size, area at risk (edema), microvascular
obstruction, intramyocardial hemorrhage were per-
formed. These latter parameters were compared
between HPR and non-HPR patients.
Results
A total of 36 patients were included in the analysis,
including 20 (55.5%) with HPR and 16 (44.4%) with
non-HPR. No relevant significant differences between
HPR and no-HPR groups were found for clinical charac-
teristics, procedural variables, and time intervals. Com-
pared with non-HPR patients, those with HPR had a
significantly higher area at risk (p=0.04) and a trend
towards higher infact size (p=0.07) (Figure 1). The
microvascular obstruction was observed in overall 5
cases (13.9%): 4 (20%) with HPR e in 1 (6.3%) with non-
HPR. The intramyocardial hemorrhage was found in 2
patients: one with HPR, but receiving a glycoprotein
IIb/IIIa inhibitor in bailout, and one with non-HPR.
Conclusions
In patients with STEMI undergoing PPCI pretreated
with a P2Y12 receptor antagonist, the presence of HPR
at the time of angiography was associated with higher
area at risk and infarct size. These findings suggest the
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